HomeCompareMGK vs JNJ

MGK vs JNJ: Dividend Comparison 2026

MGK yields 0.39% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGK wins by $195.00 in total portfolio value
10 years
MGK
MGK
● Live price
0.39%
Share price
$367.44
Annual div
$1.43
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$40.00
Full MGK calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MGK vs JNJ

📍 MGK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGKJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGK + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGK pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGK
Annual income on $10K today (after 15% tax)
$33.15/yr
After 10yr DRIP, annual income (after tax)
$34.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $669.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGK + JNJ for your $10,000?

MGK: 50%JNJ: 50%
100% JNJ50/50100% MGK
Portfolio after 10yr
$20.1K
Annual income
$433.89/yr
Blended yield
2.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MGK
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGK buys
0
JNJ buys
0
No recent congressional trades found for MGK or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGKJNJ
Forward yield0.39%3.36%
Annual dividend / share$1.43$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.2K$20.0K
Annual income after 10y$40.00$827.78
Total dividends collected$395.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MGK vs JNJ ($10,000, DRIP)

YearMGK PortfolioMGK Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,739$38.99$10,676$355.77+$63.00MGK
2$11,530$39.14$11,407$389.39+$123.00MGK
3$12,376$39.27$12,198$426.53+$178.00MGK
4$13,282$39.39$13,056$467.62+$226.00MGK
5$14,251$39.51$13,987$513.12+$264.00MGK
6$15,288$39.62$14,998$563.56+$290.00MGK
7$16,398$39.72$16,098$619.52+$300.00MGK
8$17,586$39.82$17,295$681.69+$291.00MGK
9$18,857$39.91$18,599$750.82+$258.00MGK
10$20,217$40.00$20,022$827.78+$195.00MGK

MGK vs JNJ: Complete Analysis 2026

MGKStock

Seeks to track the performance of the CRSP US Mega Cap Growth Index.Employs a passively managed, full-replication approach.Provides a convenient way to get diversified exposure to the largest growth stocks in the U.S. market.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full MGK Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MGK vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGK vs SCHDMGK vs JEPIMGK vs OMGK vs KOMGK vs MAINMGK vs ABBVMGK vs MRKMGK vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.